Results for tag: "Prostatic Hypertrophy"

Prostatic Hypertrophy (BPH) is a condition in which the prostate gland enlarges, causing urinary symptoms such as difficulty starting or stopping the flow of urine, a weak or interrupted urinary stream, and a feeling of incomplete bladder emptying. It is a common condition in men over the age of 50 and is managed by Urologists and Nephrologists. Treatment options include lifestyle changes, medications, and minimally invasive procedures. The Prostatic Hypertrophy market is a growing segment of the Urology and Nephrology industry. Companies in this market are focused on developing treatments and technologies to improve the quality of life for patients with BPH. These include pharmaceutical companies, medical device manufacturers, and healthcare providers. Some companies in the Prostatic Hypertrophy market include Allergan, Boston Scientific, Medtronic, Merck, Pfizer, and Urovant Sciences. Show Less Read more